The European Commission Approves Chrysanthemum cinerariaefolium Extract for Use in Biocidal Products of Type 18

November 3, 2023


Under Regulation (EU) No. 528/2012 of the European Parliament and the Council, the European Commission has recently reached a significant milestone by approving the use of Chrysanthemum cinerariaefolium extract. This active substance is derived from mature, open flowers of Tanacetum cinerariaefolium using an advanced technique involving supercritical carbon dioxide. Its approval is intended for use in type 18 biocidal products, marking a significant advancement in the fight against pest insects. This important announcement comes with an effective date set for February 1, 2025.

Evaluation in Compliance with Directive 98/8/EC

This regulatory advancement results from a thorough evaluation of the active substance in compliance with Directive 98/8/EC of the European Parliament and the Council. This directive covers various categories of products, including insecticides, acaricides, and other products designed to combat harmful arthropods. The comprehensive evaluation was conducted by Spain, designated as the rapporteur member state, with the evaluation report submitted to the Commission on September 1, 2010.

Approval Date

The European Commission has set the approval date for Chrysanthemum cineracinerariaefolium riaefolium extract produced using supercritical carbon dioxide from mature, open flowers of Tanacetum cinerariaefolium to be February 1, 2025. This decision aims to enhance the effectiveness of biocidal products in the battle against pest insects, a critical issue for environmental and public health protection.

Compliance Deadline

To allow stakeholders to adapt to the new requirements gradually, a compliance deadline has been carefully established before the approval of this active substance. This will enable industry players to gradually adapt to the new regulations and ensure the safe and responsible use of this potent biocidal substance.

Want to learn more about the approval of Chrysanthemum cinerariaefolium extract? How to prepare an application for product authorization or implement transitional measures for your products containing this active substance?

For more information, please don't hesitate to contact us.

Encore +

Articles similaires

Autorisation Reach

Postponement of the DEHP ban in medical devices: new dates

The European Commission recently announced a postponement of the ban on the use of bis(2-ethylhexyl) phthalate (DEHP) in medical devices (MDs).

The European Union Approves Formic Acid for Biocidal Products: Conditions and Implications

The European Parliament and the Council have approved formic acid as an existing active substance for use in biocidal products of product types 2, 3, 4, and 5, in accordance with Regulation (EU) No. 528/2012. This decision includes formic acid among the approved active substances for biocidal products and comes with specific conditions and considerations aimed at ensuring effectiveness and safety for users, as well as environmental concerns.

Publication of the 19th and 20th ATP by the European Commission

On July 11, 2023, the European Commission published in the Official Journal, the 19th and 20th ATP (Adaptation to Technical and Scientific Progress), amending Annex VI of CLP.